MiR-618 inhibits anaplastic thyroid cancer by repressing XIAP in one ATC cell line

Annales d'Endocrinologie

Volumn 75, Issue 4, 2014, Pages 187-193

  Cheng, Qianpeng ^a   Zhang, Xingguang ^a   Xu, Xiuping ^a   Lu, Xiaofeng ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 618; UNCLASSIFIED DRUG; X LINKED INHIBITOR OF APOPTOSIS; MIRN618 MICRORNA, HUMAN; XIAP PROTEIN, HUMAN;

ANAPLASTIC THYROID CANCER; ARTICLE; CANCER GROWTH; CANCER INHIBITION; CELL MIGRATION; CONTROLLED STUDY; GENE CONTROL; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE REPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; LUCIFERASE ASSAY; PREDICTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; THYROID CANCER CELL LINE; TUMOR INVASION; XIAP GENE; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CARCINOMA; CELL MOTION; CELL PROLIFERATION; DRUG EFFECTS; GENETICS; METABOLISM; MUTAGENESIS; PATHOLOGY; PLASMID; THYROID NEOPLASMS; TUMOR CELL LINE;

CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; MICRORNAS; MUTAGENESIS; NEOPLASM INVASIVENESS; PLASMIDS; THYROID NEOPLASMS; X-LINKED INHIBITOR OF APOPTOSIS PROTEIN;

EID: 84923082144     PISSN: 00034266     EISSN: 22133941     Source Type: Journal    
DOI: 10.1016/j.ando.2014.01.002     Document Type: Article

References (33)

1. Phan T., Yu X.M., Kunnimalaiyaan M., et al. Antiproliferative effect of chrysin on anaplastic thyroid cancer. J Surg Res 2011, 170(1):84-88.
2. Sandulache V.C., Skinner H.D., Wang Y., Chen Y., Dodge C.T., Ow T.J., et al. Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation. Mol Cancer Ther 2012, 11(6):1373-1380.
3. Antonelli A., Fallahi P., Ulisse S., Ferrari S.M., Minuto M., Saraceno G., et al. New targeted therapies for anaplastic thyroid cancer. Anticancer Agents Med Chem 2012, 12(1):87-93.
4. Kim E., Matsuse M., Saenko V., Suzuki K., Ohtsuru A., Mitsutake N., et al. Imatinib enhances docetaxel-induced apoptosis through inhibition of nuclear factor-κB activation in anaplastic thyroid carcinoma cells. Thyroid 2012, 22(7):717-724.
5. Wagenknecht B., Glaser T., Naumann U., Kügler S., Isenmann S., Bähr M., et al. Expression and biological activity of X-linked inhibitor of apoptosis (XIAP) in human malignant glioma. Cell Death Differ 1999, 6(4):370-376.
6. Perkins C., Kim C.N., Fang G., Bhalla K.N., et al. Over-expression of Apaf-1 promotes apoptosis of untreated and paclitaxel- or etoposide-treated HL-60 cells. Cancer Res 1998, 58(20):4561-4566.
7. Kitada S., Zapata J.M., Andreeff M., Reed J.C., et al. Protein kinase inhibitors flavopiridol and 7-hydroxy-staurosporine down-regulate anti-apoptosis proteins in B-cell chronic lymphocytic leukemia. Blood 2000, 96(2):393-397.
8. Peng X.H., Karna P., O'Regan R.M., Liu X., Naithani R., Moriarty R.M., et al. Down-regulation of inhibitor of apoptosis proteins by deguelin selectively induces apoptosis in breast cancer cells. Mol Pharmacol 2007, 1(1):101-111.
9. Frankel A., Man S., Elliott P., Adams J., Kerbel R.S., et al. Lack of multicellular drug resistance observed in human ovarian and prostate carcinoma treated with the proteasome inhibitor PS-341. Clin Cancer Res 2000, 6(9):3719-3728.
10. Okamoto W., Okamoto I., Arao T., Kuwata K., Hatashita E., Yamaguchi H., et al. Antitumor action of the MET tyrosine kinase inhibitor crizotinib (PF-02341066) in gastric cancer positive for MET amplification. Mol Cancer Ther 2012, 11(7):1557-1564.
11. Filipowicz W., Bhattacharyya S.N., Sonenberg N. Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?. Nat Rev Genet 2008, 9(2):102-114.
12. Paduano F., Dattilo V., Narciso D., Bilotta A., Gaudio E., Menniti M., et al. Protein tyrosine phosphatase PTPRJ is negatively regulated by microRNA-328. FEBS J 2013, 280(2):401-412.
13. Stanley J.A., Aruldhas M.M., Chandrasekaran M., Neelamohan R., Suthagar E., Annapoorna K., et al. Androgen receptor expression in human thyroid cancer tissues: a potential mechanism underlying the gender bias in the incidence of thyroid cancers. J Steroid Biochem Mol Biol 2012, 130(1-2):105-124.
14. Bian H.B., Pan X., Yang J.S., Wang Z.X., De W. Up-regulation of microRNA-451 increases cisplatin sensitivity of non-small cell lung cancer cell line (A549). J Exp Clin Cancer Res 2011, 30:20. 10.1186/1756-9966-30-20.
15. Shrut K., Shrey K., Vibha R. Micro RNAs: tiny sequences with enormous potential. Biochem Biophys Res Commun 2011, 407(3):445-449.
16. Dean E.J., Ward T., Pinilla C., Houghten R., Welsh K., Makin G., et al. A small molecular inhibitor of XIAP induces apoptosis and synergises with vinorelbine and cisplatin in NSCLC. Br J Cancer 2010, 102(1):97-103.
17. Rückert F., Samm N., Lehner A.K., Saeger H.D., Grützmann R., Pilarsky C. Simultaenous gene silencing of Bcl-2, XIAP and Survivin re-sensitizes pancreatic cancer cells toward apoptosis. BMC Cancer 2010, 10:379-382.
18. Yim J.H., Yoon J.H., Kim S.A., Kim W.G., Jeon M.J., Han J.M., et al. Expression of X-linked inhibitor of apoptosis protein in neoplastic thyroid disorder. J Korean Med Sci 2011, 26(9):1191-1195.
19. Gu L.Q., Li F.Y., Zhao L., Liu Y., Chu Q., Zang X.X., et al. Association of XIAP and P2X7 receptor expression with lymph node metastasis in papillary thyroid carcinoma. Endocrine 2010, 38(2):276-282.
20. Kim H.S., Chang I., Kim J.Y., Choi K.H., Lee M.S. Caspase-mediated p65 cleavage promotes TRAIL-induced apoptosis. Cancer Res 2005, 65(14):6111-6119.
21. Tillman D.M., Izeradjene K., Szucs K.S., Douglas L., Houghton J.A. Rottlerin sensitizes colon carcinoma cells to tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis via uncoupling of the mitochondria independent of protein kinase C. Cancer Res 2003, 63(16):5118-5125.
22. Kluger H.M., McCarthy M.M., Alvero A.B., Sznol M., Ariyan S., Camp R.L., et al. The X-linked inhibitor of apoptosis protein (XIAP) is up-regulated in metastatic melanoma, and XIAP cleavage by Phenoxodiol is associated with Carboplatin sensitization. J Transl Med 2007, 5:6.
23. Dong F., Guo W., Zhang L., Wu S., Teraishi F., Davis J.J., et al. Down-regulation of XIAP and induction of apoptosis by the synthetic cyclin-dependent kinase inhibitor GW8510 in non-small cell lung cancer cells. Cancer Biol Ther 2006, 5(2):165-170.
24. Carter B.Z., Milella M., Tsao T., McQueen T., Schober W.D., Hu W., et al. Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia. Leukemia 2003, 17(11):2081-2089.
25. Wang H., Yang X., Zhou Y., Wu L., Lin H.Y., Wang S., et al. Differentially expressed plasma microRNAs in premature ovarian failure patients and the potential regulatory function of miR-23a in granulosa cell apoptosis. Reproduction 2012, 144(2):235-244.
26. Shin S., Moon K.C., Park K.U., Ha E. MicroRNA-513a-5p mediates TNF-a and LPS induced apoptosis via down-regulation of X-linked inhibitor of apoptotic protein in endothelial cells. Biochimie 2012, 94(6):1431-1436.
27. Zhu W., Zhu D., Lu S., Wang T., Wang J., Jiang B., et al. miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Med Oncol 2012, 29(1):384-391.
28. Dan Xia Z., Wei Z., Cheng F., Fan L., Zou Z.J., Wang Y.H., et al. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes. Carcinogenesis 2012, 33(7):1294-1301.
29. Abdalla M.A., Haj-Ahmad Y. Promising candidate urinary microRNA biomarkers for the early detection of hepatocellular carcinoma among high-risk hepatitis C virus Egyptian patients. J Cancer 2012, 3:19-31.
30. Esposito F., Tornincasa M., Pallante P., Federico A., Borbone E., Pierantoni G.M., et al. Down-regulation of the miR-25 and miR-30d contributes to the development of anaplastic thyroid carcinoma targeting the polycomb protein EZH2. J Clin Endocrinol Metab 2012, 97(5):E710-E718.
31. Leone V., D'Angelo D., Pallante P., Croce C.M., Fusco A. Thyrotropin regulates thyroid cell proliferation by up-regulating miR-23b and miR-29b that target SMAD3. J Clin Endocrinol Metab 2012, 97(9):3292-3301.
32. Kitano M., Rahbari R., Patterson E.E., Steinberg S.M., Prasad N.B., Wang Y., et al. Evaluation of candidate diagnostic microRNAs in thyroid fine-needle aspiration biopsy samples. Thyroid 2012, 22(3):285-291.
33. Xiong Y., Zhang L., Holloway A.K., Wu X., Su L., Kebebew E. MiR-886-3p regulates cell proliferation and migration, and is dysregulated in familial non-medullary thyroid cancer. PLoS One 2011, 6(10):e24717.